文献速递类风湿关节炎

外周血优势B细胞受体克隆可预测类风湿关节炎高危个体关节炎发作

Dominant B cell receptor clones in peripheral blood predict onset of arthritis in individuals at risk for rheumatoid arthritis.
PubMed 文献 · Ann Rheum Dis · 2017-08-08

在21例自身抗体阳性RA高危个体的前瞻性队列中,用下一代BCR测序分析配对外周血和滑膜组织,发现外周血≥5个优势BCR克隆与关节炎发作显著相关,并在50例独立验证队列中验证(RR 6.3,95%CI 2.7-15,p<1×10-4)。调整临床预测规则后关联仍存在(RR 5.0,95%CI 1.2-20,p=0.024);关节炎发作时优势克隆从外周血消失并出现于滑膜组织。

要点

  • 外周血≥5个优势BCR克隆可预测RA高危个体关节炎发作。
  • 验证队列中风险比RR 6.3(95%CI 2.7-15,p<1×10-4)。
  • 发作时优势克隆从外周血转移至滑膜组织。

核心结论

  • 外周血优势BCR克隆可高准确度预测RA高危个体出现临床关节炎症状。
  • 数据提示RA发作期间这些克隆从外周血转移至靶组织。

研究设计与样本

  • 前瞻性队列研究,测试队列21例基于自身抗体阳性的RA高危个体。
  • 采用下一代BCR测序分析配对外周血和滑膜组织样本。
  • 独立前瞻性验证队列50例RA高危个体。

主要发现

  • 测试和验证队列中,外周血≥5个优势BCR克隆与随访后关节炎发作显著相关。
  • 验证队列RR 6.3(95%CI 2.7-15,p<1×10-4)。
  • 调整临床预测规则后关联仍存在,RR 5.0(95%CI 1.2-20,p=0.024)。
  • 关节炎发作时优势BCR克隆从外周血消失并出现于滑膜组织。

关键数值与推荐

  • 优势BCR克隆定义为扩增超过总 repertoire 0.5%的克隆。
  • 以外周血≥5个优势BCR克隆作为关节炎发作风险的 cut-off。

临床怎么用

  • 对自身抗体阳性RA高危个体,可考虑检测外周血优势BCR克隆以辅助预测关节炎发作。
  • ≥5个优势BCR克隆提示关节炎发作风险升高,可支持早期干预决策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The onset of seropositive rheumatoid arthritis (RA) is preceded by the presence of specific autoantibodies in the absence of synovial inflammation. Only a subset of these at-risk individuals will develop clinical disease. This impedes efforts to implement early interventions that may prevent onset of clinically manifest disease. Here we analyse whether clonal changes in the B cell receptor (BCR) repertoire can reliably predict onset of signs and symptoms. METHODS: In a prospective cohort study in 21 individuals at risk for RA based on the presence of autoantibodies, the BCR repertoire of paired peripheral blood and synovial tissue samples was analysed using next-generation BCR sequencing. BCR clones that were expanded beyond 0.5% of the total repertoire were labelled dominant. The relative risk (RR) for onset of arthritis was assessed using the presence of ≥5 dominant BCR clones as cut-off. Findings in peripheral blood were validated in an independent prospective cohort of 50 at-risk individuals. Based on the test cohort, individuals in the validation cohort were considered positive if peripheral blood at study entry showed ≥5 dominant BCR clones. FINDINGS: Both in the test and validation cohort, the presence of ≥5 dominant BCR clones in peripheral blood was significantly associated with arthritis development after follow-up (validation cohort RR 6.3, 95% CI 2.7 to 15, p<1×10-4). Even when adjusted for a recently described clinical prediction rule the association remained intact (RR 5.0, 95% CI 1.2 to 20, p=0.024). When individuals developed arthritis, dominant BCR clones disappeared from peripheral blood and appeared in synovial tissue, suggesting a direct role of these clones in disease pathogenesis. INTERPRETATION: Dominant BCR clones in peripheral blood predict onset of clinical signs and symptoms of RA in at-risk individuals with high accuracy. Our data suggest that during onset of RA these clones shift from peripheral blood to the target tissue.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Tak PP, Doorenspleet ME, de Hair MJH, et al. Dominant B cell receptor clones in peripheral blood predict onset of arthritis in individuals at risk for rheumatoid arthritis. Ann Rheum Dis. 2017. PMID: 28790026. doi:10.1136/annrheumdis-2017-211351

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。